275 related articles for article (PubMed ID: 27350081)
1. Platinum(II) carboxylato complexes containing 7-azaindoles as N-donor carrier ligands showed cytotoxicity against cancer cell lines.
Štarha P; Trávníček Z; Pazderová L; Dvořák Z
J Inorg Biochem; 2016 Sep; 162():109-116. PubMed ID: 27350081
[TBL] [Abstract][Full Text] [Related]
2. Highly and Broad-Spectrum In Vitro Antitumor Active cis-Dichloridoplatinum(II) Complexes with 7-Azaindoles.
Štarha P; Dvořák Z; Trávníček Z
PLoS One; 2015; 10(8):e0136338. PubMed ID: 26309251
[TBL] [Abstract][Full Text] [Related]
3. In vitro anticancer active cis-Pt(II)-diiodido complexes containing 4-azaindoles.
Štarha P; Trávníček Z; Vančo J; Dvořák Z
J Biol Inorg Chem; 2019 Mar; 24(2):257-269. PubMed ID: 30767079
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic malonate platinum(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidine derivatives: structural characterization and mechanism of the suppression of tumor cell growth.
Łakomska I; Hoffmann K; Wojtczak A; Sitkowski J; Maj E; Wietrzyk J
J Inorg Biochem; 2014 Dec; 141():188-197. PubMed ID: 25277461
[TBL] [Abstract][Full Text] [Related]
5. Molecular, cellular and pharmacological effects of platinum(II) diiodido complexes containing 9-deazahypoxanthine derivatives: A group of broad-spectrum anticancer active agents.
Vančo J; Trávníček Z; Křikavová R; Gáliková J; Dvořák Z; Chalupová M
J Photochem Photobiol B; 2017 Aug; 173():423-433. PubMed ID: 28662469
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and in vitro antitumor activity of platinum(II) oxalato complexes involving 7-azaindole derivatives as coligands.
Štarha P; Trávníček Z; Popa I; Dvořák Z
Molecules; 2014 Jul; 19(8):10832-44. PubMed ID: 25068781
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Antitumor Active Gold(I) Triphenylphosphane Complexes Containing 7-Azaindoles.
Štarha P; Trávníček Z; Drahoš B; Dvořák Z
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973440
[TBL] [Abstract][Full Text] [Related]
8. Platinum(II) Iodido Complexes of 7-Azaindoles with Significant Antiproliferative Effects: An Old Story Revisited with Unexpected Outcomes.
Štarha P; Vančo J; Trávníček Z; Hošek J; Klusáková J; Dvořák Z
PLoS One; 2016; 11(12):e0165062. PubMed ID: 27906967
[TBL] [Abstract][Full Text] [Related]
9. New steroidal 7-azaindole platinum(II) antitumor complexes.
Zamora A; Rodríguez V; Cutillas N; Yellol GS; Espinosa A; Samper KG; Capdevila M; Palacios O; Ruiz J
J Inorg Biochem; 2013 Nov; 128():48-56. PubMed ID: 23932925
[TBL] [Abstract][Full Text] [Related]
10. Potentiating effect of UVA irradiation on anticancer activity of Carboplatin derivatives involving 7-azaindoles.
Štarha P; Trávníček Z; Dvořák Z; Radošová-Muchová T; Prachařová J; Vančo J; Kašpárková J
PLoS One; 2015; 10(4):e0123595. PubMed ID: 25875850
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumour activity of a new trinuclear platinum compound [{cis-PtCl(NH3)2μ {trans-Pt(3-hydroxypyridine)2H2N(CH2)5NH2)2}] Cl4 in human ovarian cancer cells.
Hamad SA; Beale P; Yu JQ; Huq F
Anticancer Res; 2014 Apr; 34(4):1923-9. PubMed ID: 24692727
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiproliferative activity of hindered, chiral 1,2-diaminodiamantane platinum(II) complexes.
Bakhonsky VV; Pashenko AA; Becker J; Hausmann H; De Groot HJM; Overkleeft HS; Fokin AA; Schreiner PR
Dalton Trans; 2020 Oct; 49(40):14009-14016. PubMed ID: 33078783
[TBL] [Abstract][Full Text] [Related]
13. A hybrid platinum drug dichloroacetate-platinum(II) overcomes cisplatin drug resistance through dual organelle targeting.
Zhang Y; Guo G; Ma B; Du R; Xiao H; Yang X; Li W; Gao Y; Li Y; Jing X
Anticancer Drugs; 2015 Aug; 26(7):698-705. PubMed ID: 25811961
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological and molecular effects of platinum(II) complexes involving 7-azaindole derivatives.
Starha P; Hošek J; Vančo J; Dvořák Z; Suchý P; Popa I; Pražanová G; Trávníček Z
PLoS One; 2014; 9(3):e90341. PubMed ID: 24603594
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of trans-(4-hydroxypyridine)(ammine)dichloroplatinum(II) and its activity in the human ovarian tumour models.
Deqnah N; Qing Yu J; Beale P; Fisher K; Huq F
Med Chem; 2013 Jun; 9(4):539-44. PubMed ID: 23061563
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Features of Platinum(II) Complexes with Rigid Steric Hindrance.
Wang Z; Yu H; Gou S; Chen F; Fang L
Inorg Chem; 2016 May; 55(9):4519-28. PubMed ID: 27074104
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands.
Vrzal R; Starha P; Dvorák Z; Trávnícek Z
J Inorg Biochem; 2010 Oct; 104(10):1130-2. PubMed ID: 20673688
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.
Deqnah N; Yu JQ; Beale P; Fisher K; Huq F
Anticancer Res; 2012 Jan; 32(1):135-40. PubMed ID: 22213298
[TBL] [Abstract][Full Text] [Related]
20. Monofunctional platinum(II) complexes with potent tumor cell growth inhibitory activity: the effect of a hydrogen-bond donor/acceptor N-heterocyclic ligand.
Margiotta N; Savino S; Gandin V; Marzano C; Natile G
ChemMedChem; 2014 Jun; 9(6):1161-8. PubMed ID: 24799414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]